
OpenGate sells Nakan to trade
Los Angeles-based private equity firm OpenGate Capital has sold France-headquartered chemical compounds producer Nakan to Westlake Chemical Corporation.
In a binding offer agreed between the GP and the chemical corporation, Westlake is expected to pay around $265m in cash for the asset, according to a company announcement.
Westlake bought Nakan to expand its compounding business globally and add important speciality products and technology to its existing product portfolio.
The transaction is expected to close by early 2019, subject to regulatory approvals, completion of required employee consultation procedures and other customary closing conditions.
Company
Headquartered in Reims, France, Nakan produces chemical compounds for the automotive, medical, consumer goods and construction industries. It has eight production facilities, located in China, France, Germany, Italy, Japan, Mexico, Spain and Vietnam, as well as a research facility in France and a laboratory in the US.
The company generated around $300m in revenues in its most recent 12-month period.
People
Westlake Chemical Corporation – Albert Chao (president, CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater